poisar

Stocks · News reference

Accendra Health shares are trading lower after Citigroup downgraded the stock from Buy to Neutral rating and lowered the price target from $4.5 to $1.5.

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ACH
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. SEC EDGAR

    8-K/A filing — ACCENDRA HEALTH INC/VA/ (ACH)

    Filed: 2026-09-28 AccNo: 0001104659-26-111408 Size: 274 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 9.01: Financial Statements and Exhibits

    ACH
  2. SEC EDGAR

    8-K filing — ACCENDRA HEALTH INC/VA/ (ACH)

    Filed: 2026-09-17 AccNo: 0001104659-26-108405 Size: 1 MB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

    ACH